Hunt BioVentures

investment firm

About

Hunt BioVentures makes investments in young private and public companies with a focus on pharmaceuticals, medical devices and agricultural

Details

Founded date
Jan 1, 2001
Operating Status
Active
Investor Type
Venture Capital

Hunt BioVentures makes investments in young private and public companies with a focus on pharmaceuticals, medical devices and agricultural biotech opportunities. With a start in 2001, Hunt has continually pursued companies with clinical efficacy data or strong human proxy data, which has typically meant companies with products in various stages of clinical trials. Although this later-stage approach will always be core to Hunt’s investment strategy, Hunt will occasionally pursue pre-clinical opportunities, especially those with exceptional management teams. Another important component of the strategy is to invest alongside other experienced life science investors in either a “co-lead” or “follower” manner.

Investments

Number of Investments
Number of Lead Investments
2
0
Hunt BioVentures has made 2 investments. Their most recent investment was on Apr 3, 2012, when OvaScience raised $37M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 3, 2012 OvaScience
Series B $37M Biotechnology
Oct 12, 2006 Morphotek
Series D $40M Biotechnology

Exits

Hunt BioVentures has had 2 exits. Hunt BioVentures most notable exits include OvaScience ,   Morphotek

Date Company Name Exit Type Industry
May 10, 2013 OvaScience M&A Biotechnology Detail
Mar 22, 2007 Morphotek M&A Biotechnology Detail